Bayer (BAYRY) Plans $0.61 Annual Dividend

Bayer (OTCMKTS:BAYRY) declared an annual dividend on Monday, March 19th, Zacks reports. Shareholders of record on Tuesday, May 29th will be given a dividend of 0.614 per share on Monday, June 11th. The ex-dividend date of this dividend is Friday, May 25th.

Bayer opened at $30.77 on Friday, MarketBeat reports. The company has a quick ratio of 1.73, a current ratio of 2.21 and a debt-to-equity ratio of 0.34. Bayer has a twelve month low of $27.60 and a twelve month high of $35.41. The stock has a market cap of $101.78 billion, a price-to-earnings ratio of 16.19, a price-to-earnings-growth ratio of 2.79 and a beta of 1.18.

Bayer (OTCMKTS:BAYRY) last released its quarterly earnings results on Wednesday, February 28th. The company reported $0.42 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.31 by $0.11. Bayer had a net margin of 11.96% and a return on equity of 19.26%. The company had revenue of $10.12 billion for the quarter. research analysts forecast that Bayer will post 2.23 EPS for the current year.

BAYRY has been the topic of several analyst reports. DZ Bank reaffirmed a “buy” rating on shares of Bayer in a research note on Thursday. Zacks Investment Research raised shares of Bayer from a “sell” rating to a “hold” rating in a research note on Tuesday, March 13th. Finally, ValuEngine cut shares of Bayer from a “hold” rating to a “sell” rating in a research note on Friday, May 4th. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. Bayer presently has an average rating of “Hold” and a consensus target price of $36.00.

Bayer Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply